PDCD1 and neoplasm: By combining the inhibitor of Stat3 (nifuroxazide) with S. typhimurium carrying small interfering RNA against PD-1, Feng et al. discovered a synergistic antitumor effect on colon cancer, where potent anti-tumor immunity was strongly elicited (110).